SCHEMBL689760

SCHEMBL689760

CCCC[Si](OC)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.37
PCSK9 Q8NBP7 1/20 0.33
CYP1A2 P05177 3/20 0.32
CYP2C9 P11712 3/20 0.32
CYP2C19 P33261 3/20 0.32
PTGS2 P35354 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP19A1 P11511 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
CES2 O00748 1/20 0.32
CES1 P23141 1/20 0.32
TSHR P16473 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ALDH1A1 P00352 2/20 0.31
CYP3A4 P08684 2/20 0.31
LMNA P02545 1/20 0.31
MAPK1 P28482 1/20 0.31
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL114778 0.74 LTA4H (0.38) LTA4HPCSK9PTGS2SMN1; SMN2SIGMAR1
SCHEMBL417993 0.74 LTA4H (0.38) LTA4HPCSK9PTGS2SMN1; SMN2SIGMAR1
Hydrochloric Acid SCHEMBL27842651 0.72 LTA4H (0.36) LTA4HPCSK9PTGS2SMN1; SMN2SIGMAR1
SCHEMBL7815014 0.72 LTA4H (0.36) LTA4HPCSK9CYP1A2CYP2C9CYP2C19
SCHEMBL8992243 0.72 LTA4H (0.36) LTA4HPCSK9PTGS2SMN1; SMN2SIGMAR1
SCHEMBL528223 0.69 ALDH1A1 (0.32) SIGMAR1TSHRALDH1A1CYP3A4LMNA
SCHEMBL5049320 0.69 LTA4H (0.43) LTA4HCYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL418320 0.68 LTA4H (0.38) LTA4HPCSK9PTGS2SMN1; SMN2SIGMAR1
SCHEMBL416284 0.68 LTA4H (0.38) LTA4HPCSK9PTGS2SMN1; SMN2SIGMAR1
SCHEMBL8992480 0.67 DNM1 (0.40) LTA4HSMN1; SMN2SIGMAR1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 383 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4244232-A1 OLIGONUCLEOTIDES, REAGENTS AND PREPARATION THEREOF Biogen MA Inc. (US) 2023-09-20 EP claimed
WO-2022103842-A1 OLIGONUCLEOTIDES, REAGENTS AND PREPARATION THEREOF BIOGEN MA INC. (US) 2022-05-19 WO claimed
WO-2013102793-A2 A NOVEL PROCESS FOR THE PREPARATION OF REBAUDIOSIDE D AND OTHER RELATED NATURALLY OCCURRING SWEETENERS SU ZHOU JING HONG BIOTECH CO., LTD. (CN) 2013-07-11 WO claimed
WO-2012075277-A2 SYNTHETIC METHODS NOVOMER, INC. (US) 2012-06-07 WO claimed
EP-2037762-A4 METHOD TO PREPARE PURE CURCUMIN KIM DARRICK S H L (US) 2009-07-08 EP claimed
EP-2037762-A1 METHOD TO PREPARE PURE CURCUMIN Kim, Darrick S.H.L. (US) 2009-03-25 EP claimed
WO-2009013764-A2 PROCESS FOR PRODUCING 6(R)-[2-(8'(S)-2 ',2 '-DIMETHYLBUTYRYLOXY-2'(S),6'(R)-DIMETHYL-1,2,6,7', 8',8A'(R)- HEXAHYDRONAPHTHYL-L'(S))ETHYL]-4(R)-HYDROXY-3,4,5,6- TETRAHYDRO-2H-PYRAN-2-ONE JUBILANT ORGANOSYS LIMITED (IN) 2009-01-29 WO claimed
WO-2007143635-A1 METHOD TO PREPARE PURE CURCUMIN KIM DARRICK S (US) 2007-12-13 WO claimed
EP-4396354-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF Wave Life Sciences Ltd. (SG) 2024-07-10 EP disclosed
WO-2024145435-A2 LIPID COMPOSITIONS AND METHODS FOR DELIVERY TO IMMUNE CELLS Life Technologies Corporation (US) 2024-07-04 WO disclosed
WO-2024145281-A1 BIODEGRADABLE LIPIDS AND FORMULATIONS FOR INTRAMUSCULAR, IN VITRO, AND EX VIVO TRANSFECTION OF MRNA MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2024-07-04 WO disclosed
CN-113710660-B DOT1L degradation agent and application thereof 达纳-法伯癌症研究公司 2024-07-02 CN disclosed
CN-118139629-A Compositions and methods for editing MECP2 transcripts 波涛生命科学有限公司 2024-06-04 CN disclosed
CN-118139977-A Double-stranded oligonucleotide compositions and methods relating thereto 波涛生命科学有限公司 2024-06-04 CN disclosed
CN-1158611-A Novel quinolone-or naphthyridonecarboxylic acid derivative or salt thereof TOYAMA CHEMICAL CO LTD (JP) 1997-09-03 CN disclosed
EP-0759917-A1 NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES GILEAD SCIENCES, INC. (US) 1997-03-05 EP disclosed
EP-0743952-A1 GENERATION AND SCREENING OF SYNTHETIC DRUG LIBRARIES MARTEK BIOSCIENCES CORPORATION (US) 1996-11-27 EP disclosed
WO-1995021850-A1 GENERATION AND SCREENING OF SYNTHETIC DRUG LIBRARIES MARTEK BIOSCIENCES CORPORATION (US) 1995-08-17 WO disclosed
WO-1995021841-A1 1-β-METHYL-CARBAPENEM, COMPOSITIONS CONTAINING SAME AND METHODS OF USE MERCK & CO., INC. (US) 1995-08-17 WO disclosed
EP-0541042-A1 2,4- and 2,5-pyridine-dicarboxylic acid derivatives, process for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1993-05-12 EP disclosed